Supplements for type 2 diabetes management

The T2D adjunct stack — rationale by ingredient

Berberine 500 mg × 2–3/day with meals

The supplement with the largest effect on HbA1c, fasting glucose, postprandial glucose, and lipid profile — often comparable to metformin in head-to-head trials. Mechanism via AMPK activation. Do not combine with metformin without prescriber coordination — potential additive hypoglycaemia and altered drug levels. GI side effects are common but usually transient.

Magnesium glycinate 300–400 mg elemental/day

Hypomagnesemia is common in T2D and worsens insulin resistance. Correction modestly improves HbA1c and insulin sensitivity. Glycinate is well-tolerated; oxide is poorly absorbed.

Vitamin D3 to a 25-OH-D target of 30–50 ng/mL

Low vitamin D is common in T2D populations. Replete to target rather than megadose; effect on glycaemic control is modest but the bone, immune, and overall metabolic agenda matter.

Alpha-Lipoic Acid 600 mg/day

The supplement with the best evidence for symptomatic improvement in diabetic peripheral neuropathy. The SYDNEY-2 trial (oral ALA 600 mg/day for 5 weeks) showed significant symptom reduction. Modest insulin-sensitising effects as well.

Psyllium husk 5–10 g/day with meals

Reduces postprandial glucose excursions, improves lipid profile, supports satiety. One of the few fibre supplements with FDA-recognised cholesterol-lowering claim.

Omega-3 EPA/DHA 1–2 g/day

Cardiovascular substrate matters in T2D — the dominant cause of mortality is cardiovascular disease. Moderate-dose omega-3 supports triglyceride control and is well-tolerated. Avoid pharmacological 4 g/day doses if AFib is on the differential or established.

Vitamin B12 500–1000 µg/day if on metformin

Metformin is a well-established cause of B12 depletion (∼10–30% of long-term users). Test B12 annually on chronic metformin; supplement if low or borderline. Methylcobalamin or cyanocobalamin oral both effective.

Ceylon cinnamon 1–3 g/day (optional)

Modest postprandial glucose effects in some trials. Use Ceylon cinnamon (Cinnamomum verum), not cassia — cassia contains coumarin levels that can be hepatotoxic at chronic high doses. Effect size is small; this is a low-priority addition.